Electroclinical Improvement in a Patient with Ring Chromosome 20 Syndrome Treated with Zonisamide: A Case Report.

dopamine drug-resistant epilepsy ring chromosome 20

Journal

Journal of pediatric genetics
ISSN: 2146-4596
Titre abrégé: J Pediatr Genet
Pays: Germany
ID NLM: 101589859

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 24 07 2020
accepted: 06 02 2021
medline: 1 4 2021
pubmed: 1 4 2021
entrez: 14 8 2023
Statut: epublish

Résumé

Ring chromosome 20 or r(20) syndrome is a rare chromosomal disorder, mainly characterized by childhood-onset drug-resistant epilepsy with typical electroencephalographic findings, followed by mild to severe cognitive-behavioral decline. Recent studies support a possible role of the dopaminergic system in the epileptogenesis of this syndrome. We report the case of a 13-year-old female with mosaic r(20) who showed typical disease onset and evolution and a remarkable electroclinical improvement with zonisamide. Epilepsy related to r(20) is often medically intractable. When valproate and lamotrigine are not effective, zonisamide could be further investigated as a therapeutic option, since it acts as antifocal and it has a potential role in the prevention of dopamine depletion.

Identifiants

pubmed: 37575645
doi: 10.1055/s-0041-1726281
pii: 2000123
pmc: PMC10421690
doi:

Types de publication

Case Reports

Langues

eng

Pagination

219-223

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest None declared.

Références

Clin EEG Neurosci. 2016 Oct;47(4):330-332
pubmed: 26240087
Epilepsy Behav. 2012 Apr;23(4):409-14
pubmed: 22424860
Dev Med Child Neurol. 2006 Jan;48(1):80; author reply 80
pubmed: 16359603
Epilepsy Behav. 2018 Mar;80:215-220
pubmed: 29414555
Pediatr Neurol. 2013 Nov;49(5):368-9
pubmed: 23916860
Neurology. 2009 Oct 13;73(15):1214-7
pubmed: 19822871
J Neurol Sci. 2018 Aug 15;391:5-9
pubmed: 30103971
Epilepsia. 2009 Nov;50(11):2420-7
pubmed: 19583784
Epilepsy Res. 2016 Dec;128:83-93
pubmed: 27816898
Q J Nucl Med Mol Imaging. 2010 Oct;54(5):564-9
pubmed: 20927024
Epilepsy Behav. 2017 Sep;74:1-9
pubmed: 28654799
J Med Genet. 2011 Jan;48(1):1-9
pubmed: 20972251

Auteurs

Stefano Parravicini (S)

Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy.
Brain and Behaviour Department, University of Pavia, Pavia, Italy.

Ludovica Pasca (L)

Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy.
Brain and Behaviour Department, University of Pavia, Pavia, Italy.

Martina Paola Zanaboni (MP)

Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy.

Costanza Varesio (C)

Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy.
Brain and Behaviour Department, University of Pavia, Pavia, Italy.

Elisa Rognone (E)

Department of Neuroradiology, IRCSS Mondino Foundation, Pavia, Italy.

Martina Totaro (M)

Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy.
Brain and Behaviour Department, University of Pavia, Pavia, Italy.

Simone Gana (S)

Medical Genetics, IRCCS Mondino Foundation, Pavia, Italy.

Elena Rossi (E)

Medical Genetics, IRCCS Mondino Foundation, Pavia, Italy.
Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Valentina De Giorgis (V)

Department of Child Neurology and Psychiatry, IRCSS Mondino Foundation, European Reference Network for Rare and Complex Epilepsies, EpiCARE, Pavia, Italy.

Classifications MeSH